Mental Health & Depression: 58 new trials, 3,267 recruiting, 1,394 papers published May 18–25, Off Label Use tops 3,628 reports.
Doctiplus - We are allways here!
Doctiplus - We are allways here!
Mental Health & Depression: 58 new trials, 3,267 recruiting, 1,394 papers published May 18–25, Off Label Use tops 3,628 reports.
Cancer & Oncology: 195 new trials, 18,842 recruiting, 3,651 papers published May 18–25, 8596 off-label use reports.
Diabetes Type 2: 37 new trials, 1,977 recruiting, 3 Phase 3 trials. Off Label Use reports 10,126. May 18–25.
Heart Disease & Cardiovascular: 130 new trials, 8,752 recruiting, 2,304 papers published May 18–25, Fatigue tops adverse reports at 6,625.
Dementia & Alzheimer’s: 18 new trials, 1 Phase 3, 945 recruiting, 1,366 papers published, May 18–25.
Mental Health & Depression: 62 new trials, 3,252 recruiting, 1,353 papers published, May 11–18, Off Label Use tops 3,628 reports.
Cancer & Oncology: 211 new trials, 18,794 recruiting, 3,678 papers published May 11–18, Off Label Use tops 8,596 reports.
Diabetes Type 2: 39 new trials, 1,979 recruiting, 3 Phase 3. Off Label Use leads adverse reports at 10,229. May 11–18.
Heart Disease & Cardiovascular: 139 new trials, 8,712 recruiting, 2,123 papers published May 11–18, Fatigue leads adverse reports at 6,625.
Dementia & Alzheimer’s: 8 new trials, 937 recruiting, 1,365 papers published, May 11–18, 628 death reports.